Skip to main content
SpringerLink
Log in
Book cover

Facharztwissen Urologie pp 687–713Cite as

Allgemeine onkologische Chemotherapiee

  • Chapter

  • 974 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Anderson JR, Anderson PN, Armitage JO et al. (1996) Use of hematopoietic colony stimulating factors: evidence-based clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 12:2471–2508

    Google Scholar 

  • Barth J, Kloke M (2003) Paravasation bei Zytostatika. In: Seeber S, Schütte J (Hrsg) Therapiekonzepte Onkologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 1708–1715

    Google Scholar 

  • Gralla RJ, Osoba D, Kris MG et al. (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol 17:2971–2994

    CAS  PubMed  Google Scholar 

  • Krege S, Rübben H (2001) Chemotherapie — Hinweise zur Prophylaxe und Therapie von Komplikationen. In: Rübben H (Hrsg) Uroonkologie, 3. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 683–721

    Google Scholar 

  • Link H et al. (1999) Antimikrobielle Therapie bei unerklärtem Fieber bei Neutropenie. Dtsch Med Wochenschr 124:3–8

    Article  Google Scholar 

  • NCI Investigator’s handbook (1993) A manual for participants in clinical trials of investigational agents. National Cancer Institute, Bethesda

    Google Scholar 

  • Rizzo JD, Lichtin AE, Woolf SH et al. (2002) Use of Epoitin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 20:1–25, 2002

    Article  Google Scholar 

  • WHO (1979) Handbook for reporting results of cancer treatment No. 48. WHO, Geneva

    Google Scholar 

  • Wilde MI, Faulds D (1998) Oprelvekin: a review of its pharmacology and therapeutic potential in chemotherapyinduced thrombocytopenia. Bio Drugs 10:159–171

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologische Klinik und Poliklinik, Universitätsklinikum Essen, Hufelandstr. 5, 45147, Essen

    Priv.-Doz. Dr. med. S. Krege

Authors
  1. Priv.-Doz. Dr. med. S. Krege
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Krege, S. (2006). Allgemeine onkologische Chemotherapiee. In: Facharztwissen Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-32986-2_17

Download citation

  • DOI: https://doi.org/10.1007/3-540-32986-2_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20009-3

  • Online ISBN: 978-3-540-32986-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation